COMMUNIQUÉS West-GlobeNewswire

Fungushead Launches Veteran ‘Angel’s Wing Scholarship’ and Reaffirms Microscopy-Only Standards as California Accelerates Psychedelic Research (AB 1103)
27/10/2025
DENVER, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Fungushead , a microscopy and mycology education company, today announced two key initiatives — the launch of its Angel’s Wing Scholarship for U.S. military veterans and a [...]
Health Canada Approval of Lecanemab Offers New Hope for Ontarians Living with Alzheimer’s Disease
27/10/2025
The Alzheimer Society of Ontario calls for immediate system investments to support access to the newly approved dementia treatment TORONTO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- The Alzheimer Society of Ontario applauds the [...]
Revenue for the nine months ended 30 September 2025
27/10/2025
Press release Third-quarter organic revenue growth of +5.1% Year to date revenue at 30 September 2025 reached €3,976m, an increase of +4.9% on an organic basis All activities and regions contributed to the momentum in [...]
Chiffre d'affaires au 30 septembre 2025
27/10/2025
Communiqué de presse Le chiffre d’affaires du troisième trimestre progresse de +5,1% en base organique En rythme annuel, le chiffre d’affaires au 30 septembre 2025 s’établit à €3 976m, en progression de +4,9% en base [...]
LifeLabs Care Packages Bring Comfort to Children with Cancer at POGO Satellite Clinics
27/10/2025
Toronto, Ontario, Oct. 27, 2025 (GLOBE NEWSWIRE) -- A childhood cancer diagnosis changes everything for a family. To help provide comfort during this difficult time, LifeLabs has donated customized care packages and [...]
Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration
27/10/2025
NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Protext Mobility, Inc. (OTC: TXTM), an emerging powerhouse in botanical-based biotechnology, today announced the upcoming launch of its Investor Relations (IR) Presentation [...]
Hapbee Appoints New Leaders to Accelerate Women’s Wellness Through Frequency Healing Technology
27/10/2025
Expanding focus into FemTech positions Hapbee to scale across a USD 177 billion market by uniting neuroscience, sleep optimization, and women-led innovation VANCOUVER, British Columbia, Oct. 27, 2025 (GLOBE NEWSWIRE [...]
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
27/10/2025
Saint- Herblain (France), October 27 , 202 5 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with [...]
Valneva fera des présentations et rencontrera les investisseurs lors de conférences aux États-Unis et en Europe
27/10/2025
Saint-Herblain (France), le 27 octobre 202 5 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que des membres de son équipe dirigeante feront des [...]
Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT
27/10/2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published, first-of-its-kind comparative study of single-use negative pressure wound therapy (sNPWT) devices [...]
MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
27/10/2025
First five patients in Part C (expansion) of THIO-101 Phase 2 clinical trial enrolled in Taiwan and Turkey CHICAGO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company [...]
Prenetics Announces Oversubscribed Approximately $48 Million Equity Offering with Potential for $216 Million in Total Proceeds to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy
27/10/2025
Distinguished Investor Group Includes Kraken, American Ventures, Exodus (NYSE: EXOD), XtalPi (2228.hk), DL Holdings (1709.hk) GPTX by Jihan Wu and Leading Institutions World No. 1 and 4-time Grand Slam champion Aryna [...]
A New Era for Dermatology PAs and NPs Begins with PANP360
27/10/2025
The one-of-a-kind platform unites peer connection, clinical learning, and purpose under one home Plano, Texas, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Dermsquared is proud to announce the launch of PANP360 , a reimagined hub [...]
Prenetics Announces $48.0 Million Equity Offering to Fuel IM8’s Global Expansion and Bitcoin Treasury Strategy
27/10/2025
CHARLOTTE, N.C., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“ Prenetics ” or the “ Company ”), a leading health sciences company, today announced the successful pricing of a best efforts [...]
Clearmind Medicine Appoints Mary-Elizabeth Gifford as Chief of Global Impact to Advance US Partnerships and Governmental Engagement
27/10/2025
Vancouver, Canada, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
Longeveron® Co-Founder and Chief Science Officer Dr. Joshua Hare Interviewed on NPR’s BioTech Nation Discussing Potential Breakthrough Stem Cell Therapy for Hypoplastic Left Heart Syndrome (HLHS), a Rare Pediatric Congenital Heart Defect
27/10/2025
Laromestrocel is a proprietary, scalable, allogeneic cellular therapy being evaluated to improve the clinical outcomes of children with HLHS Full enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II) [...]
Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial
27/10/2025
Orchestra BioMed’s Virtue ® Sirolimus AngioInfusion TM Balloon (“Virtue SAB”) is the first non-coated drug-eluting balloon system designed to deliver a large liquid dose of proprietary extended-release sirolimus (“ [...]
Curia Invests $4 Million to Enhance Sterile API Manufacturing
27/10/2025
ALBANY, N.Y., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million investment to upgrade its [...]
Curia investit 4 millions de dollars pour renforcer la fabrication stérile de substances actives (API)
27/10/2025
ALBANY, New York, 27 oct. 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), l’une des principales organisations de recherche, de développement et de fabrication sous contrat, a annoncé aujourd’hui l’achèvement d’un [...]

Pages